116 related articles for article (PubMed ID: 38584456)
1. Alkylide derivatives of diphyllin: synthesis and preliminary anticancer evaluation.
Dong CH; Wang H; Ma YJ; Zhang Y; Si C; Zhao Y
J Asian Nat Prod Res; 2024 Jul; 26(7):833-842. PubMed ID: 38584456
[TBL] [Abstract][Full Text] [Related]
2. 2, 4, 5-Trideoxyhexopyranosides derivatives of diphyllin: Synthesis and anticancer activity.
Cai R; Li Y; Zhu L; Wei C; Bao X; Zhao Y
Chem Biol Drug Des; 2022 Aug; 100(2):256-266. PubMed ID: 35614538
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and bioevaluation of diphyllin glycosides as novel anticancer agents.
Zhao Y; Ni C; Zhang Y; Zhu L
Arch Pharm (Weinheim); 2012 Aug; 345(8):622-8. PubMed ID: 22592997
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Cytotoxicity, Anti-Migration and Anti-Invasion Activity of Diphyllin Heterocyclic Derivatives.
Shen W; Chen H; Wu M; Zhang T; Zhu L; Zhao Y
Med Chem; 2022; 18(1):122-129. PubMed ID: 33349219
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
Bakr RB; Mehany ABM; Abdellatif KRA
Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators.
Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM
Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, cytotoxicity and anti-invasion activity of three natural diphyllin L-arabinopyranosides.
Cai R; Zhu L; Shen W; Zhao Y
Fitoterapia; 2019 Sep; 137():104198. PubMed ID: 31175951
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and identification of cytotoxic diphyllin glycosides as vacuolar H(+)-ATPase inhibitors.
Zhang Z; Ma J; Zhu L; Zhao Y
Eur J Med Chem; 2014 Jul; 82():466-71. PubMed ID: 24929344
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor activity of biotinylated camptothecin derivatives as potent cytotoxic agents.
Zi CT; Yang L; Xu FQ; Dong FW; Ma RJ; Li Y; Zhou J; Ding ZT; Jiang ZH; Hu JM
Bioorg Med Chem Lett; 2019 Jan; 29(2):234-237. PubMed ID: 30509782
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, structure and anticancer activity of novel alkenyl-1,3,5-triazine derivatives.
Saczewski F; BuĊakowska A
Eur J Med Chem; 2006 May; 41(5):611-5. PubMed ID: 16540207
[TBL] [Abstract][Full Text] [Related]
12. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors.
Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA
Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416
[TBL] [Abstract][Full Text] [Related]
13. N-Substituted-4-phenylphthalazin-1-amine-derived VEGFR-2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluation studies.
El-Adl K; Ibrahim MK; Khedr F; Abulkhair HS; Eissa IH
Arch Pharm (Weinheim); 2021 Mar; 354(3):e2000219. PubMed ID: 33197080
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors.
El-Adl K; El-Helby AA; Sakr H; Elwan A
Bioorg Chem; 2020 Dec; 105():104399. PubMed ID: 33113414
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5-[(4-chloro/2,4-dichloro)benzylidene]thiazolidine-2,4-dione derivatives as VEGFR-2 inhibitors.
El-Adl K; El-Helby AA; Sakr H; Ayyad RR; Mahdy HA; Nasser M; Abulkhair HS; El-Hddad SSA
Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000279. PubMed ID: 33073374
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel indanone containing spiroisoxazoline derivatives with selective COX-2 inhibition as anticancer agents.
Abolhasani H; Zarghi A; Komeili Movahhed T; Abolhasani A; Daraei B; Dastmalchi S
Bioorg Med Chem; 2021 Feb; 32():115960. PubMed ID: 33477020
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and in vitro evaluation of fangchinoline derivatives as potential anticancer agents.
Zhang YC; Gao XZ; Liu C; Wang MX; Zhang RR; Sun JY; Liu YF
Bioorg Chem; 2020 Jan; 94():103431. PubMed ID: 31759658
[TBL] [Abstract][Full Text] [Related]
18. VEGFR-2 inhibiting effect and molecular modeling of newly synthesized coumarin derivatives as anti-breast cancer agents.
Ahmed EY; Abdel Latif NA; El-Mansy MF; Elserwy WS; Abdelhafez OM
Bioorg Med Chem; 2020 Mar; 28(5):115328. PubMed ID: 31992477
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Biological Evaluation of New Naphthoquinones Derivatives.
Ourhzif EM; Decombat C; Abrunhosa-Thomas I; Delort L; Khouili M; Akssira M; Caldefie-Chezet F; Chalard P; Troin Y
Curr Org Synth; 2020; 17(3):224-229. PubMed ID: 32091341
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Antitumor Activity of 1-Substituted 1,2,3-Triazole-Mollugin Derivatives.
Luo H; Lv YF; Zhang H; Hu JM; Li HM; Liu SJ
Molecules; 2021 May; 26(11):. PubMed ID: 34071319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
